RxDoctor Payments Data

Jasmine Myers, PA

Physician Assistant · Huntersville, NCNPI 1447766019

Payments from drug & device makers

$885in general payments, 2019–2025

Across 41 payments — averaging $21.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$157
  • GSK$118
  • Alkermes, Inc.$78
  • Pfizer$72
  • Actelion Pharmaceuticals US, Inc.$60
  • Sanofi-aventis U.S. LLC$58
  • plus $341 from 14 others

What the payments were for

  • Food & beverage$81492%
  • Education$718%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$885 in reported general payments places this provider in the 65th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$13,802
Medicare patients
75
Services billed
261

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol32$34,134
OzempicSemaglutide18$27,640
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$24,550
EliquisApixaban25$22,420
TrulicityDulaglutide13$21,139
MounjaroTirzepatide16$16,809
Tresiba Flextouch U-200Insulin Degludec11$12,071
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog12$8,888
Tresiba Flextouch U-100Insulin Degludec15$7,931
VascepaIcosapent Ethyl14$7,288
XareltoRivaroxaban11$6,057
LinzessLinaclotide11$5,988
Breo ElliptaFluticasone/Vilanterol12$5,549
Albuterol Sulfate HfaAlbuterol Sulfate55$1,579
Gabapentin92$1,485

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$42$34,13432 claims
GSKTrelegy Ellipta, Breo Ellipta$118$30,09940 claims
Novo NordiskOzempic$14$27,64018 claims
PfizerEliquis$72$22,42025 claims
AbbVieLinzess$157$5,98811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Huntersville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →